Arslan, S.; Unal, S.; Gokce, T.; Atasoy, B.M.; Gunduz, O.; Karademir, B.
Combination of First Generation Proteasome Inhibitor Bortezomib with Temozolomide and Radiotherapy in Glioblastoma 2D and 3D Cell Cultures. Proceedings 2018, 2, 1579.
https://doi.org/10.3390/proceedings2251579
AMA Style
Arslan S, Unal S, Gokce T, Atasoy BM, Gunduz O, Karademir B.
Combination of First Generation Proteasome Inhibitor Bortezomib with Temozolomide and Radiotherapy in Glioblastoma 2D and 3D Cell Cultures. Proceedings. 2018; 2(25):1579.
https://doi.org/10.3390/proceedings2251579
Chicago/Turabian Style
Arslan, Sema, Semra Unal, Tilbe Gokce, Beste Melek Atasoy, Oguzhan Gunduz, and Betul Karademir.
2018. "Combination of First Generation Proteasome Inhibitor Bortezomib with Temozolomide and Radiotherapy in Glioblastoma 2D and 3D Cell Cultures" Proceedings 2, no. 25: 1579.
https://doi.org/10.3390/proceedings2251579
APA Style
Arslan, S., Unal, S., Gokce, T., Atasoy, B. M., Gunduz, O., & Karademir, B.
(2018). Combination of First Generation Proteasome Inhibitor Bortezomib with Temozolomide and Radiotherapy in Glioblastoma 2D and 3D Cell Cultures. Proceedings, 2(25), 1579.
https://doi.org/10.3390/proceedings2251579
